Advertisement

Molecular and Cellular Biochemistry

, Volume 460, Issue 1–2, pp 17–27 | Cite as

Acetyl-11-keto-β-boswellic acid modulates membrane dynamics in benzo(a)pyrene-induced lung carcinogenesis

  • Priti Bhardwaj
  • Manoj Kumar
  • Sunil Kumar Dhatwalia
  • Mohan Lal Garg
  • Devinder Kumar DhawanEmail author
Article
  • 132 Downloads

Abstract

Membrane fluidity is the most important physiochemical property of cell membranes and governs its functional attributes. The current investigations were undertaken to understand the potential role of acetyl-11-keto-β-boswellic acid (AKBA), if any, on regulation of membrane dynamics under conditions of benzo(a)pyrene (BaP)-induced lung carcinogenesis in female rats. The animals were divided into five groups which included (I) Normal control, (II) Vehicle treated (olive oil), (III) BaP treated, (IV) AKBA treated and (V) BaP + AKBA treated. BaP was administered at a dose level of 50 mg/kg b.wt. in olive oil orally twice a week for 4 weeks. AKBA was given at a dose level of 50 mg/kg b.wt. in olive oil orally thrice a week for 24 weeks. In addition, AKBA was also administered at a similar dose to BaP-treated animals 4 weeks prior to BaP administration and continued for another 20 weeks. The lipid profile and membrane dynamics were analysed in lung tissue. Total lipids, phospholipids content, membrane fluidity, polarization and order of membrane were significantly (p ≤ 0.001) increased in BaP-exposed animals. However, significant decrease was observed in glycolipids, cholesterol, microviscosity and anisotropy levels compared with normal control animals. Appreciable improvements in above indices were recorded when AKBA was administered to BaP-treated animals. Moreover, the structural variations observed in Fourier-transform infrared spectroscopy spectrum were also normalized in BaP-treated rats with AKBA supplementation. This suggests that the AKBA has a potential role in improving membrane fluidity and associated lipid content in BaP-induced lung carcinogenesis.

Keywords

Lipid profile Membrane fluidity Lung cancer AKBA FT-IR 

Notes

Acknowledgement

The authors are thankful to the Department of Science and Technology, India for providing financial assistance in the form of DST-Inspire Fellowship (IF160041) to Priti Bhardwaj. The authors are also thankful to the University Grants Commission, New Delhi, India for providing financial assistance in terms of Dr. D.S. Kothari Postdoctoral Fellowship (DSKPDF) award to the co-authors (Dr. Manoj Kumar and Dr. Sunil Kumar Dhatwalia). The authors also acknowledge the financial assistance under DST-PURSE grant to the Department of Biophysics, Panjab University, Chandigarh, India.

Compliance with ethical standards

Conflict of interest

The authors declare that there are no conflicts of interest.

References

  1. 1.
    Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424CrossRefGoogle Scholar
  2. 2.
    Cooper CS, Grover PL, Sims P (1983) The metabolism and activation of benzo[a]pyrene. Prog Drug Metab 7:295–396Google Scholar
  3. 3.
    Kasala ER, Bodduluru LN, Barua CC, Sriram CS, Gogoi R (2015) Benzo (a) pyrene induced lung cancer: role of dietary phytochemicals in chemoprevention. Pharmacol Rep 67(5):996–1009CrossRefPubMedGoogle Scholar
  4. 4.
    Piyathilake CJ, Frost AR, Manne U, Bell WC, Weiss H, Heimburger DC et al (2000) The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum Pathol 31:1068–1073CrossRefPubMedGoogle Scholar
  5. 5.
    Swinnen JV, Roskams T, Joniau S, Van Poppel H, Oyen R, Baert L et al (2002) Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int J Cancer 98:19–22CrossRefPubMedGoogle Scholar
  6. 6.
    Menendez JA, Lupu R (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7:763–777CrossRefPubMedGoogle Scholar
  7. 7.
    Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674CrossRefGoogle Scholar
  8. 8.
    Maupetit P (1984) New constituents in olibanumresinoid and essential oils. Perfum Flavor 9:19–37Google Scholar
  9. 9.
    Sharma ML, Kaul A, Khajuria A, Singh S, Singh GB (1996) Immunomodulatory activity of boswellic acids (pentacyclic triterpene acids) from Boswellia serrata. Phytother Res 10:107–112CrossRefGoogle Scholar
  10. 10.
    Jing Y, Nakajo S, Xia L, Nakaya K, Fang Q, Waxman S, Han R (1999) Boswellic acid acetate induces differentiation and apoptosis in leukemia cell lines. Leukemia Res 23:43–50CrossRefGoogle Scholar
  11. 11.
    Gerhardt H, Seifert F, Buvari P, Vogelsang H, Repges R (2001) Therapy of active Crohn disease with Boswellia serrata extract H 15. Z Gastroenterol 39:11–17CrossRefPubMedGoogle Scholar
  12. 12.
    Krieglstein CF, Anthoni C, Rijcken EJ, Laukötter M, Spiegel HU, Boden SE et al (2001) Acetyl-11-keto-beta boswellic acid: a constituent of a herbal medicine from Boswellia serrata resin attenuates experimental ileitis. Int J Colorectal Dis 16:88–95CrossRefPubMedGoogle Scholar
  13. 13.
    Kumar M, Singh G, Bhardwaj P, Dhatwalia SK, Dhawan DK (2017) Understanding the role of 3-O-Acetyl-11-keto-β-boswellic acid in conditions of oxidative-stress mediated hepatic dysfunction during benzo(a)pyrene induced toxicity. Food Chem Toxicol 109:871–878CrossRefPubMedGoogle Scholar
  14. 14.
    Singh S, Khajuria A, Taneja C, Khajuria RK, Singh J, Qazi GN (2007) Boswellic acids and glucosamine show synergistic effect in preclinical anti-inflammatory study in rats. Bioorg Med Chem Lett 17:3706–3711CrossRefPubMedGoogle Scholar
  15. 15.
    Zhang Y, Duan RD (2009) Boswellic acid inhibits expression of acid sphingomyelinase in intestinal cells. Lipids Health Dis 8:51–59CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Liu JJ, Huang B, Hooi SC (2006) Acetyl-keto-beta-boswellic acid inhibits cellular proliferation through a p21-dependent pathway in colon cancer cells. Br J Pharmacol 148:1099–1107CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Yadav VR, Prasad S, Sung B, Gelovani JG, Guha S, Krishnan S, Aggarwal BB (2012) Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkers. Int J Cancer 130:2176–2184CrossRefPubMedGoogle Scholar
  18. 18.
    Gupta SC, Kim JH, Prasad S, Aggarwal BB (2010) Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 29:405–434CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Park B, Prasad S, Yadav V, Sung B, Aggarwal BB (2012) Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets. PLoS ONE 7(8):10.1371CrossRefGoogle Scholar
  20. 20.
    Sikdar S, Mukharjee A, Bishayee K, Paul A, Saha SK, Ghosh S, Khuda-bakhsh AR (2013) Post cancer treatment with condurango 30C shows amelioration of benzo[a]pyrene—induced lung cancer in rats through the molecular pathway of caspa-se-3-mediated apoptosis induction—anti-lung cancer potential of Condurango 30C in rats. J Pharmacopunct 16(3):11–22CrossRefGoogle Scholar
  21. 21.
    Folch J, Lees M, Sloane-Stanley GH (1957) A simple method for the isolation and purification of total lipids from nervous tissues. J Biol Chem 245:3584–3592Google Scholar
  22. 22.
    Fringes CS, Dunn RT (1970) A colorimetric method for determination of total serum lipids on the sulfo-phosphovanillin reaction. Am J Clin Pathol 53:89–91CrossRefGoogle Scholar
  23. 23.
    Zlatkis A, Zak B, Boyle AJ (1953) A new method for direct determination of serum cholesterol. J Lab Clin Med 41:486–492PubMedGoogle Scholar
  24. 24.
    Ames BN (1996) Assay of inorganic phosphate, total phosphate and phosphatase. In: Ginsburg V, Neufeld E (eds) Method in enzymology. Academic Press, New York, pp 115–118Google Scholar
  25. 25.
    Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F (1956) Colorimetric method for determination of sugars and related substances. Anal Chem 28:350–356CrossRefGoogle Scholar
  26. 26.
    Massey JB, Gotto AM, Pownell H (1982) Kinetics and mechanism of the spontaneous transfer of fluorescent phosphatidyl choline between apolipoprotein- phospholipid recombinants. Biochemistry 21:3630–3636CrossRefPubMedGoogle Scholar
  27. 27.
    Schachter D, Shinitzky M (1977) Fluorescence polarization studies of rat intestinal microvillus membrane. J Cli Invest 59:536–548CrossRefGoogle Scholar
  28. 28.
    Branden CI, Lindqvist Y, Schneider G (1991) Protein engineering of Rubisco. Acta Crystallogr 47:824–835CrossRefGoogle Scholar
  29. 29.
    Chow M, Der CJ, Buss JE (1992) Structure and biological effects of lipid modifications on proteins. Curr Opin Cell Biol 4:629–636CrossRefPubMedGoogle Scholar
  30. 30.
    Murata N, Los DA (1997) Membrane fluidity and temperature perception. Plant Physiol 115:875–879CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Los DA (2000) Murata N (2000) Regulation of enzymatic activity and gene expression by membrane fluidity. Sci STKE 62:pe1Google Scholar
  32. 32.
    Laroche C, Beney L, Marechal PA, Gervais P (2001) The effect of osmotic pressure on the membrane fluidity of Saccharomyces cerevisiae at different physiological temperatures. Appl Microbiol Biotechnol 56:249–254CrossRefPubMedGoogle Scholar
  33. 33.
    Spector AA, Yorek MA (1985) Membrane lipid composition and cellular function. J Lipid Res 26:1015–1035PubMedGoogle Scholar
  34. 34.
    Kinnunen PK (1991) On the principles of functional ordering in biological membranes. Chem Phys Lipids 57:375–399CrossRefPubMedGoogle Scholar
  35. 35.
    Hendrich AB, Michalak K (2003) Lipids as a target for drugs modulating multi drug resistance of cancer cells. Curr Drug Targets 4:23–30CrossRefPubMedGoogle Scholar
  36. 36.
    Van Blitterswijk WJ (1988) Structural basis and physiological control of membrane fluidity in normal and tumor cells. Subcell Biochem 13:393–413CrossRefPubMedGoogle Scholar
  37. 37.
    Inbar M, Goldman R, Inbar L, Bursuker I, Goldman B, Akstein E et al (1977) Fluidity difference of membrane lipids in human normal and leukemic lymphocytes as controlled by serum components. Cancer Res 37:3037–3041PubMedGoogle Scholar
  38. 38.
    Campanella R (1992) Membrane lipids modifications in human gliomas of different degree of malignancy. J Neurosurg Sci 36:11–25PubMedGoogle Scholar
  39. 39.
    Rodrigues CM, Sola S, Castro RE, Laires PA, Brites D, Moura JJ (2002) Perturbation of membrane dynamics in nerve cells as an early event during bilirubin-induced apoptosis. J Lipid Res 43:885–894PubMedGoogle Scholar
  40. 40.
    Sok M, Sentjurc M, Schara M, Stare J, Rott T (2002) Cell membrane fluidity and prognosis of lung cancer. Ann Thorac Surg 73:1567–1571CrossRefPubMedGoogle Scholar
  41. 41.
    Magesh V, Singh JP, Selvendiran K, Ekambaram G, Sakthisekaran D (2006) Antitumour activity of crocetin in accordance to tumor incidence, antioxidant status, drug metabolizing enzymes and histopathological studies. Mol Cell Biochem 287:127–135CrossRefPubMedGoogle Scholar
  42. 42.
    Shiizaki K, Kawanishi M, Yagi T (2017) Modulation of benzo [a] pyrene–DNA adduct formation by CYP1 inducer and inhibitor. Gene Environ 39(1):14–21CrossRefGoogle Scholar
  43. 43.
    Kavitha JV, Rosario JF, Chandran J, Anbu P (2007) Hypoglycemic and other related effects of Boswellia glabra in alloxan-induced diabetic rats. Indian J Physiol Pharmacol 51:29–39PubMedGoogle Scholar
  44. 44.
    Baritaki S, Apostolakis S, Kanellou P, Dimanche-Boitrel MT, Spandidos DA, Bonavida B (2007) Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implications. Adv Cancer Res 98:149–190CrossRefPubMedGoogle Scholar
  45. 45.
    Huang Z, McWilliams A, Lui H, McLean DI, Lam S, Zeng H (2003) Near-infrared Raman spectroscopy for optical diagnosis of lung cancer. Int J Cancer 107(6):1047–1052CrossRefPubMedGoogle Scholar
  46. 46.
    Movasaghi Z, Rehman S, Rehman DI (2008) Fourier transform infrared (FTIR) spectroscopy of biological tissues. Appl Spectrosc Rev 43(2):134–179CrossRefGoogle Scholar
  47. 47.
    Mikhail F, Denissenko K, Annie P, Moon-shong T, Gerd PP (1996) Preferential formation of benzo(a)pyrene adducts at lung cancer mutational hotspots in P53. Science 274:430–432CrossRefGoogle Scholar
  48. 48.
    Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49(11):1603–1616CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Grunberger D, Haimovitz R, Shinitzky M (1982) Resolution of plasma membrane lipid fluidity in intact cells labelled with diphenylhexatriene. Biochim Biophys Acta 688:764–774CrossRefPubMedGoogle Scholar
  50. 50.
    Ghosh PK, Mukherjee M (1995) Increase in fluidity of human placental syncytiotrophoblastic brush border membrane with advancement of gestational age: a fluorescence polarization study. Biochim Biophys Acta 1236:317–322CrossRefPubMedGoogle Scholar
  51. 51.
    Behal N, Kanwar SS, Kaur J, Sanyal SN (2008) Cyclooxygenase-2 inhibition by etoricoxib modulates plasma membrane fluidity in rat colon. J Environ Pathol Toxicol 27(4):295–302CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Priti Bhardwaj
    • 1
  • Manoj Kumar
    • 1
  • Sunil Kumar Dhatwalia
    • 1
  • Mohan Lal Garg
    • 1
  • Devinder Kumar Dhawan
    • 1
    Email author
  1. 1.Department of BiophysicsPanjab UniversityChandigarhIndia

Personalised recommendations